Subgroups | Change in GMs of NT-proBNP at 24 wk (95% CI) | Ratio of change in GM (95% CI) | P value | |
---|---|---|---|---|
Canagliflozin group | Glimepiride group | |||
All | 0.98 (0.89 to 1.08) | 1.07 (0.97 to 1.18) | 0.93 (0.82 to 1.05) | 0.244 |
SEP-e′: < 4.7 | 0.88 (0.73 to 1.05) | 1.08 (0.92 to 1.27) | 0.83 (0.66 to 1.03) | 0.083 |
SEP-e′: 4.7 to 6.4 | 1.04 (0.87 to 1.25) | 1.09 (0.91 to 1.31) | 1.02 (0.81 to 1.28) | 0.893 |
SEP-e′: ≥ 6.4 | 1.04 (0.87 to 1.25) | 1.06 (0.89 to 1.27) | 1.00 (0.78 to 1.28) | 0.992 |
E/SEP-e′: < 10.2 | 1.05 (0.87 to 1.27) | 1.01 (0.92 to 1.33) | 0.95 (0.74 to 1.22) | 0.685 |
E/SEP-e′: 10.2 to 13.9 | 1.03 (0.84 to 1.26) | 1.16 (0.97 to 1.39) | 0.98 (0.75 to 1.26) | 0.849 |
E/SEP-e′: ≥ 13.9 | 0.89 (0.76 to 1.04) | 0.96 (0.83 to 1.13) | 0.92 (0.76 to 1.12) | 0.413 |